Indian Court Sets aside Roche’s Patent-China Intellectual Property

Browse by Attribute

Browse by Column

Indian Court Sets aside Roche’s Patent

2008/12/22

Peter Ollier, Hong Kong

The Madras High Court last week set aside a patent granted to Swiss pharmaceutical company F Hoffman La Roche for its blockbuster anti-infection medicine valganciclovir because a pre-grant opposition by two NGOs was not heard.

The decision is another blow to Roche after the company failed to get a preliminary injunction in March against Indian generic drug maker Cipla, which is making its own version of Tarceva, Roche’s lung cancer medication. That case is currently under appeal.

The Madras High Court sent the valganciclovir matter back to the patent controller on December 2 and has ordered that the pre-grant opposition be heard by the end of January 2009.

From:www.managingip.com

Click Ranking

People watch

Chen Jun: Accumulation and Sublimation

It is lucky for Chen Jun to began his career in the IP industry 14 years ago when the first group of IP managers for businesses appeared on the stage in China and he has been in the industry.

Foxconn in Those Years

It was this “Whampoa Military Academy” for IP that educated China’s first batch of corporate IP management personnel. Many of these engineers left Foxconn in the years since.

2018 ANNUAL INVENTORY OF THE The Progress and Challenges of Copyright Industry in China Interview with Cheng Lingjun, Intellectual Property Director of Joyoung Co., Ltd. Interview with Chen Lingpei, General Manager of IP Division, Autodesk, Inc. (Greater China) Constant Accumulation Makes theLatecomers Surpass—Interview with Huang Lu, Director of IP Center of Humanwell Healthcare Between Lawyer and Manager —Interview with Xia Feng, the Chief IP Counsel of Greater China & Asia-Pacific, Honeywell (China) Patent Prosecution Highway and its Application Overview of EU copyright levy system – in the case of mobile phones